Chimerix Inc logo

Chimerix Inc

$ 1.82 -0.08 (-4.21%) 10:08 PM EST
P/E:
At Loss
P/B:
5.71
Market Cap:
$ 159.47M
Enterprise V:
$ 119.05M
Volume:
1.07M
Avg Vol (2M):
5.20M
Also Trade In:
Volume:
1.07M
Market Cap $:
159.47M
PE Ratio:
At Loss
Avg Vol (2-Month):
5.20M
Enterprise Value $:
119.05M
PB Ratio:
5.71
GF Score:
Year:
Embed
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Alerts Website SEC Filings Stock Report
Dataset
Financial Download

Business Description

Description
Chimerix Inc. is a biopharmaceutical company based in the United States that engages in the research, development, and commercialization of medicines. Its portfolio includes treatment for acute myeloid leukemia (or AML) and antiviral treatment for smallpox. The company generates revenue through license agreements and a federal contract with the U.S. Biomedical Advanced Research and Development Authority (BARDA) for research and advanced development of drugs to treat various human diseases. The company operates only in one business segment namely pharmaceuticals.
Name Current Vs Industry Vs History
Cash-To-Debt 18.1
Equity-to-Asset 0.52
Debt-to-Equity 0.09
Debt-to-EBITDA -0.02
Piotroski F-Score 2/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score -26.6
Distress
Grey
Safe
Beneish M-Score -8.21
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 16.43
9-Day RSI 27.66
14-Day RSI 34.92
6-1 Month Momentum % -53.19
12-1 Month Momentum % -66.95

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 2.18
Quick Ratio 2
Cash Ratio 1.84
Days Inventory 9514.81
Days Sales Outstanding 114.26
Days Payable 7219.32

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -19.6

Financials (Next Earnings Date:2022-11-04 Est.)

CMRX's 30-Y Financials

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NAS:CMRX

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
To

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

Embed

Valuation Box

Year:
Embed

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 0.608
EPS (TTM) ($) -1.21
Beta 1.28
Volatility % 67.4
14-Day RSI 34.92
14-Day ATR ($) 0.170313
20-Day SMA ($) 2.163
12-1 Month Momentum % -66.95
52-Week Range ($) 1.27 - 7.42
Shares Outstanding (Mil) 87.62

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 2
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Chimerix Inc Filings

Document Form Filing Date
No Filing Data

Chimerix Inc Analysis

Share your research

Headlines

See More
No news.